-
Nick Lowery on CNBC Revisits Power Hour Talks Kannalife Sciences
Nick Lowery, former Kansas City Chiefs Kicker and Kannalife Spokesperson, visits CNBC’s Power Hour as he holds first place in this years Stock Draft.
-
CFN Media Interviews Kannalife CEO Dean Petkanas
CFN Media Interviews Dean Petkanas of Kannalife Sciences Inc. at its LA studio.
-
Dateline NBC with Lester Holt profiles Kannalife on show “Growing Promise”
Kannalife scientist Dr. Doug Brenneman and CEO Dean Petkanas were interviewed by journalist Harry Smith on Dateline NBC Special “Growing Promise” which aired on Sunday May 20, 2018. The topics discussed were cannabidiol (cbd), the 507 Patent (#6630507) “Cannabinoids as […]
-
Former NFL great Nick Lowery talks Kannalife on CNBC
Former NFL players Nick Lowery and Eric Dickerson on CNBC. First-time Stock Draft investors on their investment strategy from CNBC.
-
Kannalife’s Nick Lowery speaks with John Chandler on NBC 4 New York about CTE
http://www.nbcnewyork.com/on-air/as-seen-on/Scientists-Announce-Breakthrough-on-CTE_New-York-448348493.html
-
Kannalife Spokesman Nick Lowery on Varney & Co on Fox Business
Watch the latest video at video.foxbusiness.com http://video.foxbusiness.com/v/5589013605001/
-
CNN’s WEED3 with Dr. Sanjay Gupta features Kannalife and CEO Dean Petkanas
Dr. Sanjay Gupta interviews Kannalife Sciences CEO Dean Petkanas and the exclusive license to the US Government’s patent on Cannabis. “Cannabinoids as Antioxidants and Neuroprotectants”. Kannalife is working on two (2) distinct disease indications that effect the Brain. One is […]
-
-
Dean Petkanas on Fox Business’ Varney & Co. with host Charles Payne
Condition at Center of NFL Lawsuit Targeted by Medical Marijuana Company A plant-based pharmaceutical company is working on developing a medical marijuana treatment for chronic traumatic encephalopathy (CTE), a degenerative disease that affects people—particularly athletes—who have suffered repeated head trauma. […]
-
Thoma Kikis on Bloomberg TV Street Smart with host Trish Regan
Aug. 4 –- Kannalife Sciences Founder Thoma Kikis and Leafly CEO Brendan Kennedy discuss using cannabinoid–based therapeutics to treat chronic traumatic encephalopathy and Leafly’s New York Times marijuana ad. They speak on “Street Smart.” (Source: Bloomberg)
-
Thoma Kikis on Bloomberg TV “Taking Stock” with host Pimm Fox
July 8 (Bloomberg) — Thoma Kikis, co-founder of KannaLife Sciences, discusses the regulation of cannabis and Cannabinoid Therapeutics with Pimm Fox on “Taking Stock.” (Source: Bloomberg)